Tumor regression after combination of radiation and PD-1 antibody nivolumab treatment in a patient with metastatic mediastinal leiomyosarcoma: a case report

The PD-1/PD-L1 axis is characterized as an important checkpoint of immune activation, particularly through negatively regulating T cell function. Although accumulated evidence has demonstrated the patients with some types of tumor benefit from blockade of PD-1/PD-L1 signaling pathway, the possible s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Biol Ther
Egile Nagusiak: Xi, Chen, Wencheng, Zhang, Dong, Qian, Yong, Guan, Cihui, Yan, Yuwen, Wang, Hualei, Zhang, Puchun, Er, Qingsong, Pang, Ping, Wang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2018
Gaiak:
Bedside to Bench Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6422505/
https://ncbi.nlm.nih.gov/pubmed/30388926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1537577
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak